BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 23422037)

  • 1. The role of semaphorins and their receptors in vascular development and cancer.
    Gu C; Giraudo E
    Exp Cell Res; 2013 May; 319(9):1306-16. PubMed ID: 23422037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis.
    Gaur P; Bielenberg DR; Samuel S; Bose D; Zhou Y; Gray MJ; Dallas NA; Fan F; Xia L; Lu J; Ellis LM
    Clin Cancer Res; 2009 Nov; 15(22):6763-70. PubMed ID: 19887479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semaphorin signaling in vascular and tumor biology.
    Neufeld G; Lange T; Varshavsky A; Kessler O
    Adv Exp Med Biol; 2007; 600():118-31. PubMed ID: 17607951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The semaphorins and their receptors as modulators of tumor progression.
    Neufeld G; Mumblat Y; Smolkin T; Toledano S; Nir-Zvi I; Ziv K; Kessler O
    Drug Resist Updat; 2016 Nov; 29():1-12. PubMed ID: 27912840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropilins: role in signalling, angiogenesis and disease.
    Zachary I
    Chem Immunol Allergy; 2014; 99():37-70. PubMed ID: 24217602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer.
    Sakurai A; Doçi CL; Gutkind JS
    Cell Res; 2012 Jan; 22(1):23-32. PubMed ID: 22157652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune semaphorins: Crucial regulatory signals and novel therapeutic targets in asthma and allergic diseases.
    Kalmarzi RN; Rajabinejad M; Lotfi R
    Eur J Pharmacol; 2020 Aug; 881():173209. PubMed ID: 32454117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifaceted role of neuropilins in cancer.
    Rizzolio S; Tamagnone L
    Curr Med Chem; 2011; 18(23):3563-75. PubMed ID: 21756227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for class 3 semaphorins in prostate cancer.
    Blanc V; Nariculam J; Munson P; Freeman A; Klocker H; Masters J; Williamson M
    Prostate; 2011 May; 71(6):649-58. PubMed ID: 20949546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin signals tweaking the tumor microenvironment.
    Muratori C; Tamagnone L
    Adv Cancer Res; 2012; 114():59-85. PubMed ID: 22588056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The semaphorins: versatile regulators of tumour progression and tumour angiogenesis.
    Neufeld G; Kessler O
    Nat Rev Cancer; 2008 Aug; 8(8):632-45. PubMed ID: 18580951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging roles and mechanisms of semaphorins activity in cancer.
    Bica C; Tirpe A; Nutu A; Ciocan C; Chira S; Gurzau ES; Braicu C; Berindan-Neagoe I
    Life Sci; 2023 Apr; 318():121499. PubMed ID: 36775114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropilins: novel targets for anti-angiogenesis therapies.
    Geretti E; Klagsbrun M
    Cell Adh Migr; 2007; 1(2):56-61. PubMed ID: 19329879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer.
    Mastrantonio R; You H; Tamagnone L
    Theranostics; 2021; 11(7):3262-3277. PubMed ID: 33537086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semaphorins and their receptors in lung cancer.
    Potiron VA; Roche J; Drabkin HA
    Cancer Lett; 2009 Jan; 273(1):1-14. PubMed ID: 18625544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semaphorins in Angiogenesis and Autoimmune Diseases: Therapeutic Targets?
    Iragavarapu-Charyulu V; Wojcikiewicz E; Urdaneta A
    Front Immunol; 2020; 11():346. PubMed ID: 32210960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class 3 semaphorin signaling: the end of a dogma.
    Potiron V; Roche J
    Sci STKE; 2005 May; 2005(285):pe24. PubMed ID: 15914725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functions of Plexins/Neuropilins and Their Ligands during Hippocampal Development and Neurodegeneration.
    Gil V; Del Río JA
    Cells; 2019 Feb; 8(3):. PubMed ID: 30823454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semaphorins in cancer.
    Neufeld G; Shraga-Heled N; Lange T; Guttmann-Raviv N; Herzog Y; Kessler O
    Front Biosci; 2005 Jan; 10():751-60. PubMed ID: 15569615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting endothelial and tumor cells with semaphorins.
    Bielenberg DR; Klagsbrun M
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):421-31. PubMed ID: 17768598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.